tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SOLTF Stock Latest News

Nxera Pharma Secures $4.8 Million Milestone Payment from Centessa
Company AnnouncementsNxera Pharma Secures $4.8 Million Milestone Payment from Centessa
5d ago
Nxera Pharma Receives $15 Million Milestone Payment as Phase 3 Schizophrenia Trial Begins
PremiumCompany Announcements
Nxera Pharma Receives $15 Million Milestone Payment as Phase 3 Schizophrenia Trial Begins
1M ago
Nxera Pharma Reaches Key Milestone in Eli Lilly Collaboration
PremiumCompany Announcements
Nxera Pharma Reaches Key Milestone in Eli Lilly Collaboration
1M ago
Nxera Pharma Reports Revenue Growth Amidst Losses
PremiumCompany Announcements
Nxera Pharma Reports Revenue Growth Amidst Losses
2M ago
Nxera Pharma Reports Strong Q1 2025 Results and Strategic Advances
PremiumCompany Announcements
Nxera Pharma Reports Strong Q1 2025 Results and Strategic Advances
2M ago
Nxera Pharma’s Schizophrenia Treatment Enters Phase 3 Trials
PremiumCompany AnnouncementsNxera Pharma’s Schizophrenia Treatment Enters Phase 3 Trials
2M ago
Sosei Group Corporation (SOLTF) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Sosei Group Corporation (SOLTF) Q1 Earnings Cheat Sheet
2M ago
Nxera Pharma’s Partner Advances Phase 2 Trial for Alcohol Use Disorder Treatment
Premium
Company Announcements
Nxera Pharma’s Partner Advances Phase 2 Trial for Alcohol Use Disorder Treatment
4M ago
Nxera Pharma Assigns Cenerimod Rights to Viatris for Japan and APAC
PremiumCompany Announcements
Nxera Pharma Assigns Cenerimod Rights to Viatris for Japan and APAC
4M ago
Nxera Pharma Corrects Financial Notice on Capital Reserve and Surplus Disposition
PremiumCompany Announcements
Nxera Pharma Corrects Financial Notice on Capital Reserve and Surplus Disposition
4M ago
Nxera Pharma Plans Capital Reserve Reduction for Shareholder Flexibility
PremiumCompany Announcements
Nxera Pharma Plans Capital Reserve Reduction for Shareholder Flexibility
5M ago
Nxera Pharma Reports Strong Revenue Growth in 2024
PremiumCompany Announcements
Nxera Pharma Reports Strong Revenue Growth in 2024
5M ago
Nxera Pharma Proposes Amendments to Enable Virtual-Only Shareholder Meetings
PremiumCompany AnnouncementsNxera Pharma Proposes Amendments to Enable Virtual-Only Shareholder Meetings
5M ago
Nxera Pharma Announces Board Changes to Enhance Strategic Oversight
Premium
Company Announcements
Nxera Pharma Announces Board Changes to Enhance Strategic Oversight
5M ago
Nxera Pharma Achieves Major Milestones in 2024, Eyes Further Growth
Premium
Company Announcements
Nxera Pharma Achieves Major Milestones in 2024, Eyes Further Growth
5M ago
SOLTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
SOLTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
Nxera Pharma Begins Key Insomnia Drug Trial in South Korea
PremiumCompany Announcements
Nxera Pharma Begins Key Insomnia Drug Trial in South Korea
7M ago
Nxera Pharma Gains Milestone Payment in Sleep Disorder Collaboration
PremiumCompany Announcements
Nxera Pharma Gains Milestone Payment in Sleep Disorder Collaboration
8M ago
Nxera Pharma Reports Robust Revenue Growth Amid Strategic Expansion
PremiumCompany Announcements
Nxera Pharma Reports Robust Revenue Growth Amid Strategic Expansion
8M ago
Nxera Pharma Reports Increased Revenue but Continues to Face Losses
PremiumCompany AnnouncementsNxera Pharma Reports Increased Revenue but Continues to Face Losses
8M ago
Nxera Pharma Reports Key Milestones and Revenue Growth
Premium
Company Announcements
Nxera Pharma Reports Key Milestones and Revenue Growth
8M ago
SOLTF Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SOLTF Upcoming Earnings Report: What to Expect?
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >